Clinico-pathological Study of Malignant Ovarian Tumor in a Tertiary Care Hospital.

Ovarian cancer is considered as one of the foremost gynecological malignancies due to its complex nature, unpredictable behavior and prognosis. Therefore, varying therapeutic strategies are necessitating an accurate diagnosis of this cancer. This study aimed to observe the frequency, age distribution, clinical presentation, gross features and histopathological pattern of the ovarian tumors among the Bangladeshi population. This cross-sectional observational study included 125 participants who were admitted in Bangabandhu Sheikh Mujib Medical University (BSMMU) with histologically proven ovarian cancer from January 2016 to December 2017. The epidemiological data and histopathological analysis of the ovarian cancer were performed. Among the 125 participants examined, the majority were in two age groups between 21-30 and 41-50 years. Histologically, serous adenocarcinoma (50.4%) was the commonest, least common being endometroid variety (0.8%). Furthermore, 40.1% of participants were presented with stage iii disease. Abdominal distention followed by abdominal pain was the main presenting complains. Adenocarcinoma is mostly serous in variety and higher in younger age group.

Preoperative Analysis of CA-I25 and its Relation with Histopathological Study in Ovarian Tumours.

Ovarian cancer (OC) is the seventh most common cancer among women in the world. Epithelial OC is the most predominant pathological subtype, with five major histotype. All five subtypes that differ in origination, pathogenesis, molecular alterations, risk factors and prognosis. The clinical presentations of ovarian tumors are variable and not specific. Most of the malignant ovarian tumor seeks medical advice at advanced stage of the disease. At that stage no effective treatment could be possible. There are several researches are going on developing a screening test for ovarian cancer. But there hasn't been much success yet. Clinical examination such as complete pelvic examination together with two investigations is used most often to screen the ovarian cancer. These investigations are transvaginal ultrasound (TVUS) and the blood test CA-125. The measurement of CA-125 level usually in combination with other modalities like bimanual pelvic examination, transvaginal ultrasonography is the proposed modality of early detection of ovarian cancer. The most promising application of this tumor marker is the screening. Therefore this cross sectional and observational study was conducted to observe the relationship of histopathological diagnosis and clinical features with serum CA-125 levels. Study conducted from January 2017 to December 2017 at Sir Salimullah Medical College& Mitford Hospital, Dhaka, Bangladesh. All admitted Gynecological patients having ovarian tumors during study period were included purposively for this study. Sample size was 50. Clinical features and preoperative findings of CA-125 level of these 50 patients were collected. Finally histopathological reports were accumulated after operative treatment. Gastrointestinal & constitutional complain, gynecologic mass and pain in abdomen were the selected symptoms. CA-125 levels were evaluated in relation with histopathological findings. The different findings were correlated with those of studies done at home and abroad. Mean age of the study population was (Mean±SD) 34.25±14.65. Histological findings among the study population showed that benign tumors were 72% (n=36) and malignant tumors were 28% (n=14). In case of benign ovarian tumors among 36 women, 94.4% (n=34) of them showed CA 125 level <35U/ml, other 5.6% (n=2) showed more than normal (>35U/ml) but range was 35-65U/ml. While 14 of the study population having histopathologically proven malignant ovarian tumor, showed the tumor marker level >35U/ml among 71.4% (n=10) and 28.6% (n=4) showed tumor marker <35U/ml. This finding was statistically significant (p=0.001). Histopathological findings revealed that there were significant increases in CA-125 levels in women with malignant serous histotype of serous cyst adenocarcinoma where range of CA-125 level were 2018.88 to 4249.63U/ml. Constitutional symptoms such as weight loss, loss of appetite, symptoms of mass effect such as urinary retention and rapidly progressing tumor were the symptoms of malignant ovarian tumors. Preoperative elevated level of CA-125 is the differentiating points of malignant serous histotype from benign ovarian tumors. This study will put forward some clues about the clinical diagnosis of ovarian tumor which may be utilized for making investigation and management plan. Also it will help for making prompt decision during pre-operative and per-operative procedures.

Induction by Misoprostol In Case of Intra Uterine Fetal Death: A Cross Sectional Study.

The objective of this study was to find out the effectiveness and safety of vaginal misoprostol in delivering the dead fetus in cases of intrauterine fetal death (IUFD). This cross sectional study was undertaken among all consecutive patients admitted at the Department of Obstetrics and Gynecology, Dhaka Medical College Hospital, Dhaka, Bangladesh, from October 2012 to September 2013, were included for this study. Vaginal misoprostol was applied in 50 cases that were admitted and diagnosed as a case of IUFD. After taking informed written consent from patients 50µgm of tablet misoprostol was introduced per vaginally into the posterior fornix. Doses were repeated in every 4 hours up to effective contraction to a maximum 6 doses. Follow up was done in hourly interval. Those who did not respond, decision for other methods like oxytocin infusion or LUCS were done. Study showed 60% (n=30) patients belonged to age group of 18-24 years. Among study population 44% (n=22) of the patients belonged to 22-32 weeks of gestation, 30% (n=15) were 33-37 weeks and 26% (n=13) were 38-42 weeks. The causes of intrauterine death were unidentified among 60% (n=30) of cases. Regarding antenatal check up 54% (n=27) had no checkup, 26% (n=13) were irregular and 20% (n=10) were regular. 60% (n=30) of the patients had less Bishop Score <3. Ninety six percent (96%) (n=48) patients responded with vaginal misoprostol and only 4% (n=2) were non responder group. Most 84% (n=42) of the cases needed 2-3 doses, only 8% (n=4) cases needed single dose and 8% (n=4) cases needed 4 to 6 doses. The induction delivery interval varied from 6 to 23 hours and maximum 52% (n=26) of the patients delivered within 12 hours. Adverse effects such as uterine hyper stimulation, tachysystole were not detected. The major complications observed like postpartum hemorrhage 4% (n=2), reduced platelet count 2% (n=1), and chorioamnionitis 4% (n=2). However minor complications like nausea, shivering and mild fever also observed in few cases. Study showed successful induction of labor by misoprostol in a shorter time with significantly less side effects.

Assessment of Quality of Life of Chronic Kidney Disease Patients Receiving Hemodialysis with Kidney Disease Quality of Life™-36 Scale.

Chronic kidney disease and the methods of its treatment play an important part in shaping the Quality of Life QOL of patients receiving dialysis. KDQOL™-36 is the most widely used instrument to evaluate health related quality of life of chronic kidney disease patients. The aim of the study was the subjective assessment of the quality of life (QOL) of patients treated with hemodialysis and also to understand the distribution of component scores of the scale with distribution of responses to individual items of the scale among the selected sample. This cross sectional study was conducted among randomly selected 151 patients of chronic kidney disease receiving hemodialysis with pre-dialysis proper education at Inpatient Department in National Institute of Kidney Diseases and Urology (NIKDU), Dhaka, Bangladesh during the period of June 2018 to December 2018. The instrument to measure the QOL was Kidney Disease and Quality of Life Bangla version 36 (KDQOL™-36). Recruited patients were interviewed with questionnaire technique to collect data with the scale which is a structured questionnaire comprised of four subscales. Mean scores ±SD of the domain of the physical and mental component summary, burden of kidney disease, symptoms and problems of kidney disease and effects of kidney disease subscales were 29.3±16.03, 16.93±13.0, 81.09±13.14 and 61.67±13.84 respectively. The mean ±SD of the combined score for all the four domains was 47.24±11.52. The rate of those with impaired QOL (mean score <66.7) was 96.7%. The most bothersome domain was burden of the kidney disease domain, where the mean scores of all the items were below 66.7. The study provides information that regular pre-dialysis attendance helps to provide the patient with proper education and thereby achieve better QOL among patients of chronic kidney disease receiving hemodialysis. By using the KDQOL™-36 scale this study finds that the domain of symptom of the kidney disease appeared to have least effect on the quality of life as the mean scores ranged higher from other subscales and in most cases the scores were above 66.7.